Abstract:
The application relates to new medicinal and cosmetic compositions comprising essential oils in combination with herbs and/or spices. The compositions may be used orally or topically.
Abstract:
The present invention provides an herbal composition which comprising a mixture of extracts obtain from Radix Ginseng, ganoderma lucidum, Cordyceps sinensis, Codonopsis pilosula, Lycium barbarum, Ligustrum lucidum, Glycyrrhiza uralensis, Hedyotis diffusa, Agastache rugosa and Prunella vulgaris. The present invention of the composition harbors anticancer effect. The present invention also provides a method of preparation an herbal composition and a method of treating cancer in a subject by administration the composition of the present invention.
Abstract:
A medicinal or cosmetic composition comprising Aloe vera in combination with at least one vitamin, a minerals concentrate, an organic oils concentrate, at least one Chinese Herb, at least one essential oil and at least one spice. The composition may be administered orally or topically.
Abstract:
This invention relates to an externally applied lotion that causes irritation or mild inflammation of the skin or mucous membranes for the purpose of relieving pain in haemorrhoids and the method of making such lotion. The formulation of the present invention contains ingredients to perform the five functions of vasoconstrictor, astringent, analgesic, antipruritic, and anesthetic. An alternate embodiment of the invention provides a formulation of the invention having a suitable viscosity to enable the lotion to be applied by a spray applicator directly to the site of application.
Abstract:
A method for increasing bioavailability of an orally administered hydrophobic pharmaceutical compound, which comprises orally administering the pharmaceutical compound to a mammal in need of treatment with the compound concurrently with an essential oil or essential oil component in an amount sufficient to provide bioavailability of the compound in the presence of the essential oil or essential oil component greater than bioavailability of the compound in the absence of the essential oil or essential oil component, wherein the essential oil or essential oil component has an activity of at least 10% inhibition at a concentration 0.01 wt.% or less in an assay that measures reduced conversion of cyclosporine to hydroxylated products using an assay system containing 250 mu g rat liver microsomes, 1 mu M cyclosporine and 1 mM reduced nicotinamide adenine dinucleotide phosphate (NADPH) in 1 ml of 0.1 M sodium phosphate buffer, pH 7.4.
Abstract:
The object of the invention is the plant composition of anti-inflammatory, anti-allergic, anti-asthmatic and/or anti-bacterial properties, which contains a combination of extracts demonstrating synergistic effects, obtained from the following plant material: the seed of Black cumin Nigella sativa , the root of Garden angelica Angelica archangelica , the herb of Meadowsweet Filipendula ulmaria, the herb of Korean mint Agastache rugose , and the cones of Hop Humulus lupulus. Furthermore, the object of the invention is the product containing plant compositions ranging between 1 and 100% of the composition described above.
Abstract:
Изобретение относится к области медицины, в частности к препаратам и биологически активным добавкам (БАД) для лечения сердечно-сосудистых заболеваний. Биологически активная добавка для лечения и предупреждения сердечно- сосудистых заболеваний содержит астрагал шерстистоцветковый ( Astragalus dasyanthus Pal l ), цветки боярышника кроваво-красного, ( Crataegus sanguinea Pall ), чабрец обыкновенный ( Thymus serpyllum L. ), шлемник байкальский ( Scutellaria baicalensis Georgi ) мяту лимонную ( Mentha longifolia ), лофант анисовый ( Agastache foeniculum ), душицу обыкновенную ( Origanum vulgare ), мелиссу ( Mellissa officinalis L. ), а также янтарную кислоту, лимонный ароматизатор, ароматизатор бергамота, при следующем соотношении компонентов, мас.%: астрагал шерстистоцветковый 60-85 лофант анисовый 5-12 цветки боярышника кроваво-красного 1 - 10 душица обыкновенная 1 -10 шлемник байкальский 1-10 мелисса 1-6 мята лимонная 1-6 чабрец обыкновенный 1 -2 янтарная кислота 0,5-1,0 лимонный ароматизатор 0,05 ароматизатор бергамота 0,15. Создан БАД для лечения и профилактики сердечно-сосудистых заболеваний. БАД не имеет побочных негативных воздействий и обеспечивают эффект улучшения сердечнососудистой деятельности, даже при однократном приеме препарата.